Miami, FL -- (ReleaseWire) -- 02/05/2014 -- Pennystocksites.com a leading online financial newsletter source, Reports on the following Companies: Plug Power Inc. (NASDAQ:PLUG), Sirius XM Holdings Inc. (NASDAQ:SIRI), Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) and AEGEA Inc. (OTCBB:AEGA).
Every day we scan the markets for the hottest stocks with the best potential for huge gains. Our vast network is second to none when it comes to delivering fast moving stocks and more importantly getting you out in front of them.
Join Us Here: http://pennystocksites.com/
Plug Power Inc. (NASDAQ:PLUG), Plug Power Inc., an alternative energy technology provider, engages in the design, development, commercialization, and manufacture of fuel cell systems for the industrial off-road markets worldwide. The company develops and sells a range of fuel cell systems comprising hydrogen-fueled Proton Exchange Membrane (PEM) systems. Its product line includes PEM GenDrive products for sale on commercial terms for industrial off-road consisting of forklift or material handling applications, with a focus on multi-shift high volume manufacturing and high throughput distribution sites. The company sells its products to businesses, government agencies, and commercial consumers through direct product sales force, original equipment manufacturers, and their dealer networks. Plug Power Inc. was founded in 1997 and is headquartered in Latham, New York.
Get a Free Technical Analysis on Plug Power Inc. (NASDAQ:PLUG): http://dailymarketreporter.com/market-scan/?symbol=PLUG
Sirius XM Holdings Inc. (NASDAQ:SIRI), Sirius XM Holdings Inc. provides satellite radio services in the United States and Canada. The company creates and broadcasts commercial-free music; sports talk and live events; comedy; news; exclusive talk and entertainment; and the comprehensive Latin music, sports, and talk programming in radio. It also provides traffic, weather, data, and information services for subscribers in cars, trucks, RVs, boats, and aircraft through SiriusXM Traffic, SiriusXM Travel Link, NavTraffic, NavWeather, SiriusXM Aviation, SiriusXM Marine, Sirius Marine Weather, XMWX Aviation, and XMWX Marine. In addition, the company offers SiriusXM programming through the SiriusXM Internet Radio App for smartphones and other connected devices, as well as online at siriusxm.com. It provides telematics and connected vehicles services, such as safety, security, and convenience services to various automotive manufacturers. The company’s satellite radios are primarily distributed through automakers and retailers, as well as through its Website. As of November 19, 2013, it had approximately 25.6 million subscribers. The company was formerly known as Sirius XM Radio Inc. and changed its name to Sirius XM Holdings Inc. in November 2013. Sirius XM Holdings Inc. was founded in 1990 and is headquartered in New York, New York.
Get a Free Technical Analysis on Sirius XM Holdings Inc. (NASDAQ:SIRI): http://dailymarketreporter.com/market-scan/?symbol=siri
Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for cancer, central nervous system disorders, sexual dysfunction, and other medical needs. Its clinical stage oncology candidates comprise Archexin, an inhibitor of the protein kinase Akt-1, which has completed a Phase IIa clinical trial for the treatment of pancreatic cancer, as well as is focusing on initiating Phase IIa clinical trials for chemo-resistant solid tumors and hematological malignancies; RX-3117, which has completed an exploratory Phase I clinical study in humans with therapeutic potential in a range of cancers, including colon, lung, and pancreatic cancer; and RX-5902, a small molecule that inhibits the phosphorylation of p68 RNA helicase and focuses on initiating Phase I clinical trials. The company’s pre-clinical pipeline consist of RX-0201-Nano, a nanoliposomal anticancer Akt inhibitor; RX-0047-Nano, a nanoliposomal anticancer HIF-1 alpha inhibitor; and RX-21101, nano-polymer anticancer. It has various collaborative research and development relationships with universities, research institutions, and other organizations, including Teva Pharmaceutical Industries; Korea Research Institute of Chemical Technology; The University of Maryland Baltimore; Revaax Pharmaceuticals LLC; and Rexgene Biotech Co., Ltd. The company is based in Rockville, Maryland.
Get a Free Technical Analysis on Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN): http://pennystocksites.com/market-scan/?symbol=rnn
AEGEA Inc. (OTCBB:AEGA), AEGEA Inc. focuses on operating a community and destination resort in South Florida. Its resort would offer various entertainment activities, including special seasonal and cultural events, concerts and shows, street music, and sporting events; indoor and outdoor tournament stadium, and training venues; luxury residencies and resort accommodations; and shops, restaurants, and hotels. The company is based in North Palm Beach, Florida.
Get a Free Technical Analysis on AEGEA Inc. (OTCBB:AEGA): http://pennystocksites.com/market-scan/?symbol=aega
We are not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit http://pennystocksites.com/disclaimer/ for complete risks and disclosures.